SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $163,000 | -1.2% | 15,941 | +6.2% | 0.04% | -44.4% |
Q1 2016 | $165,000 | +16.2% | 15,011 | -2.5% | 0.06% | 0.0% |
Q4 2015 | $142,000 | -20.2% | 15,390 | -40.0% | 0.06% | -25.9% |
Q3 2015 | $178,000 | +2.3% | 25,644 | +44.5% | 0.08% | +11.8% |
Q2 2015 | $174,000 | +32.8% | 17,751 | +20.4% | 0.08% | -11.6% |
Q1 2015 | $131,000 | – | 14,742 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |